跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,677 条关于
“LINDIS Biotech”
全部
6,677
临床试验
1,349
药物
807
机构
388
资讯
4,133
去年
Lindis Biotech and Pharmanovia Partner to Relaunch Catumaxomab for Malignant Ascites
去年
Federal Jury Awards Lindis Biotech $50 Million in Patent Infringement Case Against Amgen's Blincyto
去年
Pharmanovia In-Licenses Catumaxomab for Malignant Ascites Treatment
去年
CHMP Recommends Approval of Lindis Biotech's Korjuny (catumaxomab) for Malignant Ascites
9个月前
Pharmanovia Launches First-in-Class Korjuny (Catumaxomab) in Germany for Malignant Ascites Treatment
去年
Catumaxomab Receives European Marketing Authorization for Malignant Ascites Treatment
去年
Lindis Blood Care's CATUVAB Device Achieves 100% Tumor Cell Removal in Pivotal Cancer Surgery Study
去年
GenScript Biotech and NSG Bio Form Strategic Partnership to Accelerate Biotech Innovation in Singapore
去年
BPGbio Named 2024 BioTech AI Company of the Year for AI-Driven Drug Discovery
5个月前
Key Phase 3 Trials from Moderna, Sarepta, and Krystal Biotech Set to Drive 2026 Biotech Performance
第 1 页,共 414 页
上一页
下一页